[So-called pulmonary shock].
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000503:physiopathology*; D012769:Shock / Q000503:physiopathology* / Q000628:therapy; D012773:Shock, Surgical / Q000175:diagnosis; D012774:Shock, Traumatic / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D011663:Pulmonary Surfactants; D007611:Aprotinin; D008775:Methylprednisolone
Zum Problem der sogenannten Schocklunge